Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Stockholder-Equity" stands at 23.85 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Total Stockholder Equity" stands at 23.85 Billion USD. This represents an increase of 29.98 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.55 percent compared to the value the year prior.
The 1 year change in percent is 66.55.
The 3 year change in percent is 134.62.
The 5 year change in percent is 377.40.
The 10 year change in percent is 56.49.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Total Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Stockholder Equity | 280,205,508,085.11 |
![]() | Novartis AG - Total Stockholder Equity | 255,096,620,580.91 |